Comparison of Hypomethylator Monotherapy with Hypomethylator plus Chemotherapy for Intermediate/High-Risk MDS or AML: A Meta-Analysis

Aim: This meta-analysis aimed to compare the efficacy, survival benefit and safety of hypomethylating agents (HMA) monotherapy and combination with chemotherapy in patients with intermediate/high-risk MDS or AML. Methods: Related articles published between January 2009 and April 2019 were selected a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Jiang, Chen, Miao, Han, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086269/
https://www.ncbi.nlm.nih.gov/pubmed/32226512
http://dx.doi.org/10.7150/jca.40614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086269/
https://www.ncbi.nlm.nih.gov/pubmed/32226512
http://dx.doi.org/10.7150/jca.40614

Ejemplares similares